Akutni inferiorni infarkt miokarda izazvan embolizacijom distalne prednje descendentne arterije trombom iz glavnog stabla leve koronarne arterije uspešno lečen bez perkutane koronarne intervencije
Sažetak
Uvod. Tromboza glavnog stabla leve koronarne arterije (GSLKA) predstavlja retku ali potencijalno smrtonosnu manifestaciju akutnog koronarnog sindroma. Standardni pristup u lečenju takvih bolesnika jeste primarna perkutana koronarna intervencija (pPKI) ili hirurška revaskularizacija miokarda (coronary artery bypass graft surgery). U određenim slučajevima, na osnovu morfološkog izgleda tromba, nalaza i protoka dobijenih metodom koronarne angiografije (KAn), kliničke slike, kao i iskustva kardiologa, jedan od načina lečenja može biti i konzervativni pristup intenzivnom antitrombocitnom terapijom. Prikaz bolesnika. Muškarac star 37 godina primljen je u jedinicu za hitne slučajeve jer je pokazivao znake akutnog infarkta miokarda sa ST elevacijom dijafragmalne lokalizacije. Urađena je hitna KAn tokom koje je pronađen tromb u proksimalnoj trećini GSLKA, bez potpune opstrukcije protoka krvi. Inicijalno, primenjena je dvojna antitrombocitna terapija (tikagrelor i acetilsalicilna kiselina), a u daljoj proceduri odlučeno je da se uvede inhibitor glikoproteinskog IIb/IIIa receptora trombocita (tirofiban) u vidu intrakoronarnog bolusa (0,3 µg/kg), a zatim kao kontinuirana infuzija (0,1 µg/kg/min). Četiri dana kasnije, urađeni su kontrolna KAn i intravaskularna ehokardiografija, nakon čega je odlučeno da se nastavi samo sa konzervativnom terapijom, bez procedure pPKI. Bolesnik je bez tegoba, u dobrom stanju, otpušten na kućno lečenje osmog dana nakon prijema u bolnicu, uz planirano intenzivno praćenje u daljem toku oporavka. Zaključak. U slučaju neopstruktivnih trombocitnih masa bez značajne aterosklerozne stenoze, može se razmotriti modalitet konzervativnog lečenja upotrebom agresivne antitrombocitne terapije.
Reference
Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res 2014; 114(12): 1852‒66.
Lee MS, Dahodwala MQ. Percutaneous coronary intervention for acute myocardial infarction due to unprotected left main coronary artery occlusion: status update 2014. Catheter Car-diovasc Interv 2015; 85(3): 416‒20.
Arora NP, Joumaa M, Rosman H, Mehta R. Left Main Coronary Artery Thrombosis with Acute Myocardial Infarction: A Man-agement Dilemma. Am J Med Sci 2017; 353(6): 597‒602.
Mahmoudi M, Delhaye C, Wakabayashi K, Torguson R, Xue Z, Suddath WO, et al. Integrilin in patients undergoing primary percutaneous coronary intervention for ST-elevation myocar-dial infarction. J Interv Cardiol 2011; 24(4): 351‒6.
Shah I, Khan SO, Malhotra S, Fischell T. Eptifibatide: the evi-dence for its role in the management of acute coronary syn-dromes. Core Evid 2010; 4: 49–65. Erratum in: Core Evid 2014; 9: 49.
Akcay M. Evaluation of thrombotic left main coronary artery occlusions; old problem, different treatment approaches. Indi-an Heart J 2018; 70(4): 573‒4.
Patel M, Bhangoo M, Prasad A. Successful percutaneous treat-ment of suspected embolic left main thrombosis in a patient with a mechanical aortic valve. J Invasive Cardiol 2011; 23(11): E263–6.
Grion DDS, Grion DC, Silverio IV, Oliveira LS, Larini IF, Mar-tins AV, et al. Percutaneous Coronary Intervention in Unpro-tected Left Main Coronary Artery Lesions. Arq Bras Cardiol 2021; 116(6): 1101‒8. (English, Portuguese)
Ali M, Becker RC. Bridging Anticoagulation with Mechanical Heart Valves: Current Guidelines and Clinical Decisions. Curr Cardiol Rep 2020; 22(11): 130.
Hudec S, Hutyra M, Precek J, Latal J, Nykl R, Spacek M, et al. Acute myocardial infarction, intraventricular thrombus and risk of systemic embolism. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2020; 164(1): 34‒42.
Kappetein AP, Head SJ, Osnabrugge RL, van Mieghem NM. Role of percutaneous coronary intervention in the treatment of left main coronary artery disease. Semin Thorac Cardiovasc Surg 2014; 26(3): 187‒91.
Apostolakis E, Tsigkas G, Baikoussis NG, Koniari I, Alexopoulos D. Acute left main coronary artery thrombosis due to cocaine use. J Cardiothorac Surg 2010; 5: 65.
Olcay A. Concomitant left main coronary artery and prosthetic mitral valve thrombosis treatment. Anatol J Cardiol 2018; 20(6): 365‒7.
Vinod VC, Yousif ZE, Salim NO, Majwal T. Proximal Left Main Coronary Artery Aneurysm Presenting as ST-Elevation Myocardial Infarction Treated by Stenting. Case Rep Cardiol 2020; 2020: 8833917.
Dunn S, Dave N, Rodriguez-Blanco YF, Aljure O. Incidental find-ing of a left atrial thrombus during surgical management of a massive pulmonary embolism. Ann Card Anaesth 2020; 23(1): 87‒9.
Thomopoulou S, Sfirakis P, Spargias K. Angioplasty, stenting and thrombectomy to correct left main coronary stem obstruction by a bioprosthetic aortic valve. J Invasive Cardiol 2008; 20(4): E124–5.
Ayari J, Mourali MS, Farhati A, Mechmeche R. Left main coro-nary artery thrombosis revealing angio-Behçet syndrome. Egypt J Intern Med 2014; 26(2): 88‒90.
Sanchez-Recalde A, Calvo Orbe L, Galeote G. Cardiogenic shock due to complete thrombotic occlusion of the left main coro-nary ostium in a young female. J Invasive Cardiol 2006; 18(6): E188–90.
Fajadet J, Chieffo A. Current management of left main coro-nary artery disease. Eur Heart J 2012; 33(1): 36–50b.
Choi J, Kim IS, Cho S, Kim JS, Hong SJ, Shin DH, et al. Optimal Duration for Dual Antiplatelet Therapy After Left Main Cor-onary Artery Stenting. Circ J 2020; 85(1): 59‒68.
Chandrasekhar J, Baber U, Sartori S, Aquino M, Tomey M, Kruckoff M, et al. Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry. Int J Cardiol 2017; 243: 132‒9.
Lee HJ, Yu CW, Hwang HK, Choi RK, Park JS, Li H, et al. Long-term effectiveness and safety of triple versus dual an-tiplatelet therapy after percutaneous coronary intervention for unprotected left main coronary artery disease. Coron Artery Dis 2013; 24(7): 542‒8.
Sarma J, Laan CA, Alam S, Jha A, Fox KA, Dransfield I. In-creased platelet binding to circulating monocytes in acute cor-onary syndromes. Circulation 2002; 105(18): 2166–71.
Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2021; 42(14): 1289–367.